It is getting pretty thin in major analyst coverage as firms are encouraged to go easy on major year-end calls barring anything unexpected. These are the top analyst upgrades, downgrades, and new…
These are the top pre-market upgrades and positive analyst calls we have seen from Wall Street this Monday morning: Altria (NYSE: MO) Raised to Overweight at JPMorgan. Best Buy (NYSE: BBY) Raised…
It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally you see a pattern. This month the only pattern seems to be…
Gilead Sciences Inc. (NASDAQ: GILD) has just issued its third quarter earnings at $0.52 net EPS and $0.55 non-GAAP EPS and $1.37 billion in revenue. First Call had estimates at $0.49 non-GAAP…
Douglas A. McIntyre Gilead Sciences Inc. (NASDAQ: GILD) is trading down this morning. Goldman Sachs maintained its buy rating on the stock, but took down its price target to $58 from $59. This report is…
Douglas A. McIntyre There are surprisingly few analyst calls today, but these are some of the top positive calls and upgrades with more than two hours to the market open: Diebold (DBD) Raised to Buy…
These are not all of the Downgrades or negative analyst calls seen this morning but these are some of the top calls seen this Friday morning: Best Buy (NYSE: BBY) Cut to…
These are ten of the analyst calls we are seeing early this Thursday morning in early bird pre-market trading hours: American International Group (NYSE: AIG) raised to Buy at Citigroup. Bare Escentuals…
Gilead Sciences, Inc. (NASDAQ: GILD) posted results after the close today. Its Q1 revenues surged to $1.26 billion and non-GAAP earnings was $522.1 million, or $0.54 EPS. First Call had estimates at…
Douglas A. McIntyre After today’s close, we’ll get to see earnings out of Gilead Sciences Inc. (NASDAQ: GILD). The estimates for the biopharmaceutical company from First Call are $0.48 EPS on $1.22 billion in revenues. …
Douglas A. McIntyre On tonight’s Mad Money on CNBC, Jim Cramer said he’s officially going "cautious" and noted that you can’t just start recommending stocks in the current market. He noted that we haven’t even…
Douglas A. McIntyre These are some of the research calls we are looking at this morning that are impacting shares in early pre-market trading: Arcelor Mittal (NYSE: MT) raised to Buy at Deutsche Bank. Discovery…
These are not all of the pre-market research calls during a busy earnings morning, but these are the top calls that 247WallSt.com is looking at: Adobe Systems (NASDAQ: ADBE) downgraded to Underperform…
We’ve had a lot of biotech stocks see their shares get the wrath of news over recent days. Now that the November-end NASDAQ Short Interest has been released, we wanted to see…
THURSDAYAdvanced Micro Devices (NYSDAQ:AMD)Ameritrade (NASDAQ:AMTD)Bank of America (NYSE:BAC)Bank of New York (NYSE:BK)Cemex (NYSE:CX/ADR)Continental Airlines (NYSE:CAL)Cypress Semi (NYSE:CY)Dow Jones (NYSE:DJ)Fifth Third Bancorp (NASDAQ:FITB)First Data (NYSE:FDC)Gilead Sciences (NASDAQ:GILD)Google (NASDAQ:GOOG)Harley-Davidson (NYSE:HOG)Honeywelll (NYSE:HON)Illinois Tool Works (NYSE:ITW)International…